Logo image of IRCP

IRSA PROPIEDADES COMERCI-ADR (IRCP) Stock Fundamental Analysis

USA - NASDAQ:IRCP - US4635881034 - ADR

2.4984
+0.14 (+5.86%)
Last: 5/27/2022, 8:11:24 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to IRCP. IRCP was compared to 63 industry peers in the Real Estate Management & Development industry. IRCP may be in some trouble as it scores bad on both profitability and health. IRCP is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

IRCP Yearly Net Income VS EBIT VS OCF VS FCFIRCP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 20B -20B

1.2 Ratios

Industry RankSector Rank
ROA -17.47%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IRCP Yearly ROA, ROE, ROICIRCP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 20 -20 40 -40 60 -60

1.3 Margins

Industry RankSector Rank
OM 35.92%
PM (TTM) -184.81%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IRCP Yearly Profit, Operating, Gross MarginsIRCP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 100 -100 200 300

More info and screens

2

2. Health

2.1 Basic Checks

The number of shares outstanding for IRCP remains at a similar level compared to 1 year ago.
IRCP has a better debt/assets ratio than last year.
IRCP Yearly Shares OutstandingIRCP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M 100M
IRCP Yearly Total Debt VS Total AssetsIRCP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 50B 100B 150B 200B

2.2 Solvency

A Debt/Equity ratio of 0.48 indicates that IRCP is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
IRCP Yearly LT Debt VS Equity VS FCFIRCP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 20B 40B 60B 80B 100B

2.3 Liquidity

IRCP has a Current Ratio of 1.89. This is a normal value and indicates that IRCP is financially healthy and should not expect problems in meeting its short term obligations.
IRCP has a Quick Ratio of 1.88. This is a normal value and indicates that IRCP is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.89
Quick Ratio 1.88
IRCP Yearly Current Assets VS Current LiabilitesIRCP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 5B 10B 15B 20B

More info and screens

2

3. Growth

3.1 Past

The earnings per share for IRCP have decreased strongly by -180.04% in the last year.
The Revenue has decreased by -9.54% in the past year.
IRCP shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 23.32% yearly.
EPS 1Y (TTM)-180.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-112.9%
Revenue 1Y (TTM)-9.54%
Revenue growth 3Y0.33%
Revenue growth 5Y23.32%
Sales Q2Q%95.46%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year30.42%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IRCP Yearly Revenue VS EstimatesIRCP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 5B 10B 15B 20B
IRCP Yearly EPS VS EstimatesIRCP Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 0 200 400

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
IRCP Price Earnings VS Forward Price EarningsIRCP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IRCP Per share dataIRCP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 14.23%, IRCP is a good candidate for dividend investing.
IRCP's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 14.23%

5.2 History

The dividend of IRCP is nicely growing with an annual growth rate of 142.52%!
IRCP has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)142.52%
Div Incr YearsN/A
Div Non Decr YearsN/A
IRCP Yearly Dividends per shareIRCP Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 0.05 0.1 0.15 0.2

5.3 Sustainability

DPN/A
EPS Next 2YN/A
EPS Next 3YN/A
IRCP Yearly Income VS Free CF VS DividendIRCP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 0 20B -20B

More info and screens

IRSA PROPIEDADES COMERCI-ADR

NASDAQ:IRCP (5/27/2022, 8:11:24 PM)

2.4984

+0.14 (+5.86%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)03-01 2022-03-01/amc
Earnings (Next)N/A N/A
Inst Owners0.02%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap338.05M
Analysts86.67
Price Target2.55 (2.07%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 14.23%
Yearly Dividend17.94
Dividend Growth(5Y)142.52%
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpSN/A
BVpSN/A
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.47%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 35.92%
PM (TTM) -184.81%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.89
Quick Ratio 1.88
Altman-Z N/A
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-180.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-112.9%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.54%
Revenue growth 3Y0.33%
Revenue growth 5Y23.32%
Sales Q2Q%95.46%
Revenue Next Year30.42%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A